Protein Engineering and Antibody Technologies, Merck Healthcare KGaA, Darmstadt, Germany.
Protein Engineering and Antibody Technologies, EMD Serono, Billerica, MA, USA.
Methods Mol Biol. 2023;2681:313-325. doi: 10.1007/978-1-0716-3279-6_17.
The recent advent of microfluidic-assisted antibody hit discovery as standard methodology accelerated pharmaceutical research. While work on compatible recombinant antibody library approaches is ongoing, the major source of antibody-secreting cells (ASCs) remains to be primary B cells of mostly rodent origin. As fainting viability and secretion rates can lead to false-negative screening results, careful preparation of these cells is an essential prerequisite for successful hit discovery. We here describe procedures to enrich plasma cells from relevant tissues of mice and rats and plasmablasts from human blood donations. Although freshly prepared ASCs yield the most robust results, suitable freezing and thawing protocols to preserve the viability and antibody secretory function can circumvent extensive process time and allow transferring of samples between laboratories. An optimized procedure is described to yield similar secretion rates after prolonged storage when compared to freshly prepared cells. Finally, the identification of ASC-containing samples can increase the probability of success of droplet-based microfluidics-two methods for pre- or in-droplet staining are described. In summary, the preparative methods described herein can facilitate robust and successful microfluidic antibody hit discovery.
微流控辅助抗体发现作为标准方法的出现加速了药物研究。虽然正在进行兼容的重组抗体文库方法的工作,但抗体分泌细胞(ASC)的主要来源仍然是主要来自啮齿动物的原代 B 细胞。由于活力和分泌率降低可能导致假阴性筛选结果,因此仔细准备这些细胞是成功发现命中的必要前提。我们在这里描述了从相关组织中富集来自小鼠和大鼠的浆细胞以及从人血液捐赠物中富集浆母细胞的程序。尽管新鲜制备的 ASC 产生最强大的结果,但合适的冷冻和解冻方案可保存活力和抗体分泌功能,可以避免广泛的处理时间,并允许在实验室之间转移样品。当与新鲜制备的细胞相比,描述了一种优化的程序,以在长时间储存后产生相似的分泌率。最后,鉴定含有 ASC 的样品可以增加基于液滴的微流控的成功概率-描述了两种用于预或在液滴内染色的方法。总之,本文描述的制备方法可以促进强大和成功的微流控抗体命中发现。